Conjoined twins who were separated at 11 months old go home from hospitalThe Ruffin twins' story highlights the emotional journey of overcoming medical challenges and the impact of postpartum depression on mothers.
New Jersey college student suffering from sickle cell disease has newfound hope with gene therapy at CHOPGene therapy at Children's Hospital of Philadelphia offers new hope for sickle cell disease, potentially being a life-changing treatment.
New sickle cell treatment has roots at Children's Hospital of PhiladelphiaThe FDA has approved the first gene therapy treatments for sickle cell disease, a blood disorder that primarily affects people of color.The gene therapy was tested at Children's Hospital of Philadelphia and has shown promising results in patients.
New sickle cell treatment has roots at Children's Hospital of PhiladelphiaThe FDA has approved the first gene therapy treatments for sickle cell disease, a blood disorder that primarily affects people of color.The gene therapy was tested at Children's Hospital of Philadelphia and has shown promising results in patients.
New Jersey college student suffering from sickle cell disease has newfound hope with gene therapy at CHOPGene therapy at Children's Hospital of Philadelphia offers new hope for sickle cell disease, potentially being a life-changing treatment.
New sickle cell treatment has roots at Children's Hospital of PhiladelphiaThe FDA has approved the first gene therapy treatments for sickle cell disease, a blood disorder that primarily affects people of color.The gene therapy was tested at Children's Hospital of Philadelphia and has shown promising results in patients.
New sickle cell treatment has roots at Children's Hospital of PhiladelphiaThe FDA has approved the first gene therapy treatments for sickle cell disease, a blood disorder that primarily affects people of color.The gene therapy was tested at Children's Hospital of Philadelphia and has shown promising results in patients.
New sickle cell treatment has roots at Children's Hospital of PhiladelphiaThe FDA has approved the first gene therapy treatments for sickle cell disease, a blood disorder that primarily affects people of color.The gene therapy was tested at Children's Hospital of Philadelphia and has shown promising results in patients.